PDF) Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age

PDF | Routine administration of quadrivalent meningococcal conjugate vaccine to adolescents and certain high risk groups is recommended in the United | Find, read and cite all the research you need on ResearchGate

Quadrivalent (A, C, Y, W135) meningococcal conjugate vaccine

PDF) Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2–10 years: A Phase II/III double-blind randomized controlled trial - ScienceDirect

An evaluation of emerging vaccines for childhood meningococcal disease, BMC Public Health

Vaccines, Free Full-Text

An evaluation of emerging vaccines for childhood meningococcal disease, BMC Public Health

Full article: Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label

Full article: Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence

Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages - ScienceDirect

Full article: An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine

Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2–10 years of age - ScienceDirect